Fig. 1From: A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignanciesPhase I trial outline. a Schematic of the patient cohorts including patient numbers and treatment regimens evaluated in this study. b Treatment schedules employed in this Phase I studyBack to article page